Zobrazeno 1 - 10
of 100
pro vyhledávání: '"T Yu, Semiglazova"'
Autor:
A. I. Stukan, S. I. Kutukova, E. A. Nefedova, V. A. Porkhanov, V. N. Bodnya, T. Yu. Semiglazova, N. A. Tsygan, V. V. Kudrina, I. I. Aseeva, Yu. Yu. Stefanova, A. A. Kurmanaliev, M. A. Chagiev
Publikováno v:
Опухоли головы и шеи, Vol 14, Iss 1, Pp 16-30 (2024)
Introduction. Chemotherapy in combination with targeted therapy (CT + TT) using a monoclonal antibody against epidermal growth factor receptor (EGFR) cetuximab and subsequent maintenance targeted therapy (CT + TT/TT) is the leading 1st line therapy o
Externí odkaz:
https://doaj.org/article/0b76fc9e06f24009ad086a171ed0dc63
Autor:
A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko
Publikováno v:
Опухоли головы и шеи, Vol 13, Iss 4, Pp 101-115 (2024)
Introduction. Cigarette smoking along with alcohol consumption, infection with human papilloma (HPV) and the Epstein–Barr viruses, is one of the main risk factors for head and neck squamous cell carcinoma. It can also contribute to virus-associated
Externí odkaz:
https://doaj.org/article/1307ead25fc14680a2f8a42add62fd5f
Autor:
A. I. Stukan, T. Yu. Semiglazova, S. I. Kutukova, V. A. Porkhanov, V. N. Bodnya, E. N. Imyanitov, V. V. Antipova, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 4, Pp 63-74 (2024)
Background. Data on the prognostic role of the PIK3CA mutation in hormone receptor-positive (HR+) HER2-negative (HER2–) breast cancer (BC) are contradictory; nevertheless, there are indications of its negative predictive and prognostic significance
Externí odkaz:
https://doaj.org/article/88640b6bad6447928620a2997b883c2b
Autor:
V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 16-24 (2023)
Background. Breast cancer is the main cause of morbidity and mortality of the female population among economically developed countries, including in Russia. Despite the continued increase in morbidity, mortality is decreasing, which is confirmed by a
Externí odkaz:
https://doaj.org/article/026f70f8695d4c6f9f85d908899efae1
Autor:
R. M. Paltuev, O. A. Volynshchikova, Sh. R. Abdullaeva, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, Yu. A. Belaya, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, A. Yu. Vorontsov, E. A. Gaysina, A. A. Gofman, V. N. Dmitriev, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinova, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, A. S. Chichkanova, L. A. Churilova, M. V. Shomova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 30-36 (2023)
Background. Individual molecular characteristics of a tumor can serve as a basis for a tailored approach to therapy, prediction of the disease course and outcome, and timely treatment correction in cancer patients. Tumor genomic profiling allows for
Externí odkaz:
https://doaj.org/article/bb685938706842a0aee783498c6077ee
Autor:
R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 56-68 (2023)
Aim. To increase the efficacy of systemic breast cancer therapy and reduce inappropriate prescriptions using individual immunohistochemical tumor characteristics, as well as to develop prognostic scales to ensure a tailored approach to adjuvant syste
Externí odkaz:
https://doaj.org/article/0912cd61a86340dd8c2b80d35f9f8d94
Autor:
R. M. Paltuev, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, O. A. Volynshchikova, A. Yu. Vorontsov, E. A. Gaysina, A. A. Hoffman, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinovа, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, L. A. Churilova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 69-81 (2023)
Background. Breast cancer is one of the most common female malignancies. Molecular diagnostic methods of tumor profiling allow us to analyze individual tumor characteristics, identify new prognostic and predictive markers. Aim. To increase the effica
Externí odkaz:
https://doaj.org/article/cc538d9ba3a84480917cd97d5f495115
Autor:
D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 48-55 (2023)
Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients
Externí odkaz:
https://doaj.org/article/f7969acdde894223bd4331d72b66866d
Autor:
Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 3, Pp 26-32 (2022)
Background. Alkylating drugs have been used in tumor chemo therapy for many decades, and the search for effective compounds continues.The aim of the study was to study the activity of the developed new compound – 2-[3-(2-chloroethyl)-3-nitrosoureid
Externí odkaz:
https://doaj.org/article/927a039666544620aa7d17ba11e70d64
Autor:
P. V. Krivorotko, V. V. Mortada, R. S. Pesotskiy, A. S. Artemyeva, A. S. Emelyanov, S. S. Ereshchenko, G. A. Dashyan, N. S. Amirov, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, M. M. Mortada, K. Yu. Zernov, E. K. Zhiltsova, V. O. Smirnova, Ya. I. Bondarchuk, D. A. Enaldieva, S. N. Novikov, E. A. Busko, A. V. Chernaya, P. I. Krzhivitskiy, R. M. Paltuev, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 29-39 (2022)
Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exc
Externí odkaz:
https://doaj.org/article/1dba194b85a7496f8bacea07c8744896